MICHELLE ADDISON: Open Payments
NPI 1043820251 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,477 in 191 payments from 21 companies in 2025. Trend: 2023 $2,623 · 2024 $3,716 · 2025 $3,477
Food & beverage: $3,390Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $681 |
| Janssen Biotech, Inc. | 30 | $619 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $341 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $276 |
| PFIZER INC. | 7 | $200 |
| Lilly USA, LLC | 13 | $193 |
| Ardelyx, Inc. | 7 | $174 |
| GENZYME CORPORATION | 7 | $170 |
| Ipsen Biopharmaceuticals, Inc | 8 | $166 |
| QOL Medical, LLC | 7 | $142 |
Products named: TREMFYA, RINVOQ, XIFAXAN, ENTYVIO, OMVOH, DUPIXENT, IBSRELA, IQIRVO.
Industry payments across NY — which companies pay providers there.
